Strides Pharma Science Ltd - 532531 - Promoter Pledge Reduces By Over 38%
Promoter pledge reduces by over 38%17-05-2021
17-05-2021
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 17, 2021 for Pronomz Ventures LLP & Karuna Business Solutions LLP17-05-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our intimation letter dated May 12, 2021 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements regarding completion of dispatch of Notice of Postal Ballot dated May 10, 2021, published in Business Standard (English - Edition) and in Lokmat (Marathi Edition). A copy of the said advertisement is also hosted on the Company's website at www.strides.com This is for your information and records.13-05-2021
Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In line with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we enclose herewith Notice of Postal Ballot dated May 10, 2021, seeking approval of Members for 'Re-appointment of Mr. Bharat Shah (DIN: 00136969) as an Independent Director of the Company'.12-05-2021
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 11, 2021 for Sajjan D11-05-2021
Strides Pharma Science Ltd - 532531 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 11, 2021 for Sajjan D11-05-2021
Strides Pharma Science Ltd - 532531 - Intimation On Re-Appointment Of Independent Director Of The Company
We wish to inform you that Board of Directors of the Company at their meeting held today i.e., May 10, 2021, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Members of the Company, have approved the proposal for re-appointment of Mr. Bharat Dhirajlal Shah (DIN: 00136969), as an Independent Director of the Company, for a second term of three years from June 15, 2021 upto June 14, 2024. The Company proposes to seek Members' approval for the above proposal by way of Postal Ballot. Additional details pursuant to Regulation 30 and other relevant provisions of the SEBI Listing Regulations is enclosed. This is for your information and record.10-05-2021
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 10, 2021 for Sajjan D10-05-2021
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding request received for issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Prafull Kumar Singh03-05-2021
Strides Pharma Science Ltd - 532531 - Reg: Certificate Pursuant To Regulation 40 (9) Of SEBI (LODR) Regulations, 2015.
Pursuant to Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate for the half year ended on March 31, 2021 duly certified by the Practicing Company Secretary. Request you to kindly take the same on record.22-04-2021